Problems related to the febrile neutropenia in persons with cancer

Authors

  • Yaily Pérez Rizo
  • Manuel Agustín Pérez de Corcho Rodríguez
  • Jorge José Pérez Assef
  • Maribel Araujo Mejías
  • Vivian María Couse Herrera
  • José Manuel González Cendán

Abstract

A bibliographical revision was carried out with the aim to recommend thean educational intervention strategy to prevent the febrile neutropenia in adult person with cancer in Ciego de
Avila municipality. A search was carried out in different database available in Infomed, in order to determine tendencies from the application of certain instruments and techniques, these one were compared with national and foreigner updated literature. The recommended strategy of educational intervention will help to the control and prevention of febrile neutropenia in person with cancer by means of the prevention of problems related to this disease. It implements a guide for its initial handling, acting energetically in order to avoid the antimicrobial resistance that constitutes a feasible guide borne out by the experts' opinion.

Downloads

Download data is not yet available.

Author Biographies

Yaily Pérez Rizo

Residente de 2do Año de Medicina Interna.

Manuel Agustín Pérez de Corcho Rodríguez

Especialista de 2do Grado en Medicina Interna. Máster en Urgencias Médicas en Atención Primaria de Salud. Máster en Enfermedades Infecciosas. Investigador Agregado. Profesor Auxiliar.

Jorge José Pérez Assef

Especialista de 2do Grado en Medicina Interna. Máster en Enfermedades Infecciosas. Profesor Asistente.

Maribel Araujo Mejías

Especialista de 1er Grado en Anatomía Patológica. Profesor Instructor.

Vivian María Couse Herrera

Especialista de 1er Grado en Pediatría. Máster en Enfermedades Infecciosas. Profesor Asistente.

José Manuel González Cendán

Especialista de 1er Grado en Medicina Interna. Máster en Longevidad Satisfactoria. Profesor Asistente.

References

Organización Mundial de la Salud. Cáncer. Nota descriptiva No. 297 [Internet]. Washington: OPS; 2013 [citado 12 Feb 2013] [aprox. 3 pantallas]. Disponible en: http://www.ncbi.nlm.nih.gov/sites/entrez?db=mesh

Organización Panamericana de la Salud. El cáncer es la segunda causa de muerte en América Latina [Internet]. Washington: OPS; 2010 [citado 12 Feb 2013] [aprox. 2 pantallas]. Disponible en: http://new.paho.org/uru/index.php?option=com_content&task=view&id=216&Itemid=1

Céspedes Quevedo MC, Lavado Fernández JA, Almenares Elías B, Edward Seringe S, Padilla Arencibia M. Infección intrahospitalaria en pacientes con cáncer. MEDISAN [Internet]. 2010 [citado 12 Feb 2013]; 14(8): [aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1029-30192010000800012&script=sci_arttext&tlng=en

Organización Panamericana de la Salud. Programas nacionales de control del cáncer: políticas y pautas para la gestión [Internet]. Washington: OPS; 2004 [citado 12 Feb 2013] [aprox. 17 pantallas]. Disponible en:

Sansó Soberats FJ, Alonso Galbán P, Torres Vidal RM. Mortalidad por cáncer en Cuba. Rev Cubana Salud Pública [Internet]. 2010 [citado 2013 Abr 23]; 36(1): 78-94. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662010000100009&lng=es).

Cavalli F. Cáncer. El gran desafío. La Habana: Ciencias Médicas; 2012.

Soler Santana R, Soler Santana AL, Carbonell García IC, Brossard Cisneros M. Mortalidad por tumores malignos en Santiago de Cuba durante 2010. MEDISAN [Internet]. 2011 [citado 27 Mar 2013]; 15(11): 1510-1516. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011001100002&lng=es

Torres HA. Neutropenia febril: una revisión del tema [Internet]. 2004 [citado 6 Mar 2013] [aprox. 12 pantallas]. Disponible en: http://vitae.ucv.ve/pdfs/VITAE_3187.pdf

Neutropenia y fiebre [Internet]. 2011[citado 6 Mar 2013] [aprox. 5 pantallas]. Disponible en: ttp://www.intramed.net/sitios/librovirtual1/pdf/librovirtual1_55.Pdf

Lyman G, Michels S, Reynolds M, Barron R, Smoyer Tomic K, Yu J. Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia. Cancer [Internet]. 2010 [citado 12 Mar 2013]. [aprox. 12 pantallas]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/cncr.25332/full

Kim P, Wu Y, Cooper Ch, Rochester G, Valappil T, Wang Y, et al. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis. 2010; 51(4): 381-9.

Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011; 52(4): e56-93.

Gaytán-Martínez J, Ávila-Morán M, Mata-Marín JA, Mateos-García E, Fuentes-Allen JL, Vela-Ojeda J. et al. Patrones de susceptibilidad bacteriana en infecciones en pacientes adultos con neoplasias hematológicas, fiebre y neutropenia. Gaceta Méd México. 2011; 147: 325-32.

Paul M, Yahav D, Bivas A, Fraser A, Leibovivi. Anti-seudomonal betalactams for the initial, empirical, treatment of febrile neutropenia: comparison of betalactams (Review): Evid Based Child Health [Internet]. 2011[citado 12 mar 2013]; 6(6):2026-2185. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005197.pub3/pdf/standard

Feifled AG, Bovv EJ, Sepkovvitz KA. Clinical practice gudeline for the use of antimicrobial agents in neutropenic patients vvith cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011; 52:e56-e 93.

De Naurois J, Novitzky-Basso I, Guill MJ. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010; 21 (5): 252-6.

Goulart Rosa R. Impacto da aderência ao programa de controle de antimicrobianos na mortalidade de pacientes com neutropenia febril [Internet]. 2012[citado 12 Mar 2013]. [apro. 65 pantallas]. Disponible en: http://www.lume.ufrgs.br/handle/10183/53148

Garzón JR, Cuervo S, Gómez J, Cortés JA. Farmacocinética y farmacodinamia de antimicrobianos: A propósito de pacientes con neutropenia y fiebre. Rev Chil Infect. 2011; 28 (6): 537-545

Puentes GA, Quiroga C, Álvarez CA, Támara JR, Ruiz A. Características demográficas, morbilidad y mortalidad de los pacientes adultos con neutropenia febril tratados con cefepima. Rev Chilena Infectol. 2012; 29(3): 322-328.

Lami Casaus L, Arbesú Michelena MA, Sarmiento SA, Brito Iglesia R. Aparición de episodios de neutropenia febril tras la quimioterapia citostática en el paciente oncológico. Rev Cubana Farm. 2009; 43(4):68-73.

Al-Hasan MN, Eckel-Passow JE, Baddour LM. Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011; 66: 1156 – 1160.

Downloads

Published

2014-12-19

How to Cite

1.
Pérez Rizo Y, Pérez de Corcho Rodríguez MA, Pérez Assef JJ, Araujo Mejías M, Couse Herrera VM, González Cendán JM. Problems related to the febrile neutropenia in persons with cancer. Mediciego [Internet]. 2014 Dec. 19 [cited 2025 Dec. 7];20(1). Available from: https://revmediciego.sld.cu/index.php/mediciego/article/view/129

Issue

Vol. 20 No. 1 (2014)

Section

Review article

License

Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):

You are free to:

  • Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.

The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.